节点文献

胰高血糖素样肽-1及其类似物治疗2型糖尿病的优势

Superiority of GLP-1 and Its Analogues in Treating Type 2 Diabetes Mellitus

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨胜华杨华章

【Author】 YANG Sheng-hua1,YANG Hua-zhang 2(1.Medical College of Shantou University,Guangdong Shantou 515041,China;2.Department of Endocrinology,Guangdong General Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China)

【机构】 汕头大学医学院广东省人民医院内分泌科广东省医学科学院

【摘要】 胰高血糖素样肽-1是肠道L细胞分泌的一种十分重要的肠促胰岛素,其主要生理作用包括进食后刺激胰岛素的分泌和释放,抑制胰高血糖素的分泌,促进β细胞的增殖并抑制其凋亡,抑制胃排空,促进饱食感的产生等。胰高血糖素样肽-1类似物同样具有上述作用。但与其他降血糖药物相比,胰高血糖素样肽-1及其类似物在β细胞保护及降低体重方面具有独特优势。因此,胰高血糖素样肽-1类似物作为新型的治疗2型糖尿病药物,可改变糖尿病的自然进程。

【Abstract】 GLP-1 is an important incm in secreted by intestinal L cells,of which the main physiological effects are stimulating the secretion and releasing of insulin after eating,inhibiting the secretion of hyporglycosemia,promoting the proliferation of β-cell in pancreas while inhibiting its apoptosis,inhibiting gastric evacuation,improving the feeling of overeating and so on.GLP-1 analogues have the same effect above.However,compared with other hypoglycemic drugs,GLP-1 and its analogues in the β cell protection,and weight-loss have a unique advantage.Therefore,GLP-1 analogues which is a new treatment of type 2 diabetes drugs,can change the natural process of diabetes.

  • 【文献出处】 循证医学 ,The Journal of Evidence-Based Medicine , 编辑部邮箱 ,2010年06期
  • 【分类号】R587.105
  • 【被引频次】7
  • 【下载频次】320
节点文献中: 

本文链接的文献网络图示:

本文的引文网络